Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes

doi:10.1186/1743-7075-5-17

Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Nutr Metab (Lond). 2008; 5: 17.

Published online 2008 June 12. doi: 10.1186/1743-7075-5-17

PMCID: PMC2441623

Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes

Amanda M Gonzales¹ and Robert A Orlando¹

Author information ► Article notes ► Copyright and License information ►

This article has been cited by other articles in PMC.

Abstract

Background

Adipocytes express inflammatory mediators that contribute to the low-level, chronic inflammation found in obese subjects and have been linked to the onset of cardiovascular disorders and insulin resistance associated with type 2 diabetes mellitus. A reduction in inflammatory gene expression in adipocytes would be expected to reverse this low-level, inflammatory state and improve cardiovascular function and insulin sensitivity. The natural products, curcumin and resveratrol, are established anti-inflammatory compounds that mediate their effects by inhibiting activation of NF-κB signaling. In the present study, we examined if these natural products can inhibit NF-κB activation in adipocytes and in doing so reduce cytokine expression.

Methods

Cytokine (TNF-α, IL-1β, IL-6) and COX-2 gene expression in 3T3-L1-derived adipocytes was measured by quantitative real-time PCR (qRT-PCR) with or without TNFα-stimulation. Cytokine protein and prostaglandin E₂(PGE₂) expression were measured by ELISA. Effects of curcumin and resveratrol were evaluated by treating TNFα-stimulated adipocytes with each compound and 1) assessing the activation state of the NF-κB signaling pathway and 2) measuring inflammatory gene expression by qRT-PCR and ELISA.

Results

Both preadipocytes and differentiated adipocytes express the genes for TNF-α, IL-6, and COX-2, key mediators of the inflammatory response. Preadipocytes were also found to express IL-1β; however, IL-1β expression was absent in differentiated adipocytes. TNF-α treatment activated NF-κB signaling in differentiated adipocytes by inducing IκB degradation and NF-κB translocation to the nucleus, and as a result increased IL-6 (6-fold) and COX-2 (2.5-fold) mRNA levels. TNF-α also activated IL-1β gene expression in differentiated adipocytes, but had no effect on endogenous TNF-α mRNA levels. No detectable TNFα or IL-1β was secreted by adipocytes. Curcumin and resveratrol treatment inhibited NF-κB activation and resulted in a reduction of TNF-α, IL-1β, IL-6, and COX-2 gene expression (IC₅₀= 2 μM) and a reduction of secreted IL-6 and PGE₂(IC₅₀~ 20 μM).

Conclusion

Curcumin and resveratrol are able to inhibit TNFα-activated NF-κB signaling in adipocytes and as a result significantly reduce cytokine expression. These data suggest that curcumin and resveratrol may provide a novel and safe approach to reduce or inhibit the chronic inflammatory properties of adipose tissue.

Articles from Nutrition & Metabolism are provided here courtesy of BioMed Central

Related citations in PubMed

Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses. [Biochimie. 2010]
Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses.
Kang L, Heng W, Yuan A, Baolin L, Fang H. Biochimie. 2010 Jul; 92(7):789-96. Epub 2010 Feb 25.
Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. [Biochem Pharmacol. 2007]
Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A. Biochem Pharmacol. 2007 May 1; 73(9):1434-45. Epub 2007 Jan 7.
Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway. [Biomed Environ Sci. 2009]
Curcumin, a potential inhibitor of up-regulation of TNF-alpha and IL-6 induced by palmitate in 3T3-L1 adipocytes through NF-kappaB and JNK pathway.
Wang SL, Li Y, Wen Y, Chen YF, Na LX, Li ST, Sun CH. Biomed Environ Sci. 2009 Feb; 22(1):32-9.
Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells. [Diabetologia. 2008]
Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells.
Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, Théâtre E, Verhaeghe C, Magnusson NE, Chariot A, et al. Diabetologia. 2008 Jul; 51(7):1213-25. Epub 2008 May 8.
Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells. [Endocrinology. 1998]
Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K, Shichiri M, Marumo F, Hirata Y. Endocrinology. 1998 Nov; 139(11):4506-12.

See reviews... See all...

Cited by other articles in PMC

Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals [Annual review of nutrition. 2010]
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Aggarwal BB. Annual review of nutrition. 2010 Aug 21; 30173-199
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III [Evidence-based Complementary and Alternativ...]
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
Vojdani A, Lambert J, Kellermann G. Evidence-based Complementary and Alternative Medicine : eCAM. 2011; 2011548086
Mycobacterium tuberculosis protein kinase K confers survival advantage during early infection in mice and regulates growth in culture and during persistent infection: implications for immune modulation [Microbiology. 2010]
Mycobacterium tuberculosis protein kinase K confers survival advantage during early infection in mice and regulates growth in culture and during persistent infection: implications for immune modulation
Malhotra V, Arteaga-Cortés LT, Clay G, Clark-Curtiss JE. Microbiology. 2010 Sep; 156(Pt 9)2829-2841
Targeting STAT3 in cancer: how successful are we? [Expert opinion on investigational drugs. 20...]
Targeting STAT3 in cancer: how successful are we?
Yue P, Turkson J. Expert opinion on investigational drugs. 2009 Jan; 18(1)45-56

See all...

Recent activity

Clear Turn Off Turn On

Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine express...
Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes
Nutrition & Metabolism. 517

PMC
Prevention of hypertension, cardiovascular damage and endothelial dysfunction wi...
Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts.
Am J Hypertens. 2007 Dec ;20(12):1321-8.

PubMed
Characteristics of catechin- and theaflavin-mediated cardioprotection.
Characteristics of catechin- and theaflavin-mediated cardioprotection.
Exp Biol Med (Maywood). 2008 Apr ;233(4):427-33.

PubMed
Green tea reduces LDL oxidability and improves vascular function.
Green tea reduces LDL oxidability and improves vascular function.
J Am Coll Nutr. 2008 Apr ;27(2):209-13.

PubMed
Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low do...
Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice.
Arch Pharm Res. 2003 Jul ;26(7):559-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Obesity, metabolic syndrome, and coronary atherosclerosis. [Circulation. 2002]

Grundy SM

Circulation. 2002 Jun 11; 105(23):2696-8.
Review Leptin, gut, and food intake. [Biochem Pharmacol. 2002]

Attele AS, Shi ZQ, Yuan CS

Biochem Pharmacol. 2002 May 1; 63(9):1579-83.
Review Adipose tissue as an endocrine and paracrine organ. [Int J Obes Relat Metab Disord. 1998]

Mohamed-Ali V, Pinkney JH, Coppack SW

Int J Obes Relat Metab Disord. 1998 Dec; 22(12):1145-58.

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. [Science. 1993]

Hotamisligil GS, Shargill NS, Spiegelman BM

Science. 1993 Jan 1; 259(5091):87-91.
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. [Endocrinology. 2004]

Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW

Endocrinology. 2004 May; 145(5):2273-82.
Review The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. [Obes Surg. 2004]

Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR

Obes Surg. 2004 May; 14(5):589-600.
Review Adipose tissue, inflammation, and cardiovascular disease. [Circ Res. 2005]

Berg AH, Scherer PE

Circ Res. 2005 May 13; 96(9):939-49.

Review Adipose tissue, inflammation, and cardiovascular disease. [Circ Res. 2005]

Berg AH, Scherer PE

Circ Res. 2005 May 13; 96(9):939-49.
Obesity-induced inflammatory changes in adipose tissue. [J Clin Invest. 2003]

Wellen KE, Hotamisligil GS

J Clin Invest. 2003 Dec; 112(12):1785-8.
Obesity is associated with macrophage accumulation in adipose tissue. [J Clin Invest. 2003]

Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr

J Clin Invest. 2003 Dec; 112(12):1796-808.
Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. [Biochem Biophys Res Commun. 2006]

Permana PA, Menge C, Reaven PD

Biochem Biophys Res Commun. 2006 Mar 10; 341(2):507-14.
Review Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. [Endocrinology. 2003]

Rajala MW, Scherer PE

Endocrinology. 2003 Sep; 144(9):3765-73.
A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. [Arterioscler Thromb Vasc Biol. 2005]

Suganami T, Nishida J, Ogawa Y

Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2062-8.
Review The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis. [Front Biosci. 2005]

Andreakos E, Sacre S, Foxwell BM, Feldmann M

Front Biosci. 2005 Sep 1; 10():2478-88.

Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. [Am J Physiol Endocrinol Metab. 2004]

Berg AH, Lin Y, Lisanti MP, Scherer PE

Am J Physiol Endocrinol Metab. 2004 Dec; 287(6):E1178-88.
Review The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. [Obes Surg. 2004]

Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR

Obes Surg. 2004 May; 14(5):589-600.
Review Inflammatory status and insulin resistance. [Curr Opin Clin Nutr Metab Care. 2002]

Grimble RF

Curr Opin Clin Nutr Metab Care. 2002 Sep; 5(5):551-9.
Review Is type II diabetes mellitus a disease of the innate immune system? [Diabetologia. 1998]

Pickup JC, Crook MA

Diabetologia. 1998 Oct; 41(10):1241-8.

Review Inhibitors of NF-kappaB signaling: 785 and counting. [Oncogene. 2006]

Gilmore TD, Herscovitch M

Oncogene. 2006 Oct 30; 25(51):6887-99.
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. [J Med Chem. 2006]

Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM, Orlando RA, Deck LM, Jagt DL

J Med Chem. 2006 Nov 30; 49(24):7182-9.
Review Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). [J Altern Complement Med. 2003]

Chainani-Wu N

J Altern Complement Med. 2003 Feb; 9(1):161-8.
Review Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. [Anticancer Res. 2004]

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y

Anticancer Res. 2004 Sep-Oct; 24(5A):2783-840.

TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. [Biochem Pharmacol. 2006]

Weber WM, Hunsaker LA, Gonzales AM, Heynekamp JJ, Orlando RA, Deck LM, Vander Jagt DL

Biochem Pharmacol. 2006 Oct 16; 72(8):928-40.

An established pre-adipose cell line and its differentiation in culture. [Cell. 1974]

Green H, Meuth M

Cell. 1974 Oct; 3(2):127-33.
Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line. [J Cell Physiol. 1979]

Green H, Kehinde O

J Cell Physiol. 1979 Oct; 101(1):169-71.
Adipose conversion of ob17 cells and hormone-related events. [Int J Obes. 1985]

Vannier C, Gaillard D, Grimaldi P, Amri EZ, Djian P, Cermolacce C, Forest C, Etienne J, Negrel R, Ailhaud G

Int J Obes. 1985; 9 Suppl 1():41-53.

A role for preadipocytes as macrophage-like cells. [FASEB J. 1999]

Cousin B, Munoz O, Andre M, Fontanilles AM, Dani C, Cousin JL, Laharrague P, Casteilla L, Pénicaud L

FASEB J. 1999 Feb; 13(2):305-12.

Obesity is induced in mice heterozygous for cyclooxygenase-2. [Prostaglandins Other Lipid Mediat. 2001]

Fain JN, Ballou LR, Bahouth SW

Prostaglandins Other Lipid Mediat. 2001 Jul; 65(4):199-209.

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. [Endocrinology. 2004]

Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW

Endocrinology. 2004 May; 145(5):2273-82.
Review Adipose tissue, adipokines, and inflammation. [J Allergy Clin Immunol. 2005]

Fantuzzi G

J Allergy Clin Immunol. 2005 May; 115(5):911-9; quiz 920.
A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. [Arterioscler Thromb Vasc Biol. 2005]

Suganami T, Nishida J, Ogawa Y

Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2062-8.
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. [J Clin Invest. 2003]

Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H

J Clin Invest. 2003 Dec; 112(12):1821-30.

Review NF-kappaB regulation in the immune system. [Nat Rev Immunol. 2002]

Li Q, Verma IM

Nat Rev Immunol. 2002 Oct; 2(10):725-34.

Review Naturally occurring NF-kappaB inhibitors. [Mini Rev Med Chem. 2006]

Nam NH

Mini Rev Med Chem. 2006 Aug; 6(8):945-51.
Review Molecular targets of dietary agents for prevention and therapy of cancer. [Biochem Pharmacol. 2006]

Aggarwal BB, Shishodia S

Biochem Pharmacol. 2006 May 14; 71(10):1397-421.
Review Natural products as targeted modulators of the nuclear factor-kappaB pathway. [J Pharm Pharmacol. 2002]

Bremner P, Heinrich M

J Pharm Pharmacol. 2002 Apr; 54(4):453-72.

Review Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. [BJOG. 2006]

Cancello R, Clément K

BJOG. 2006 Oct; 113(10):1141-7.
Review Adipose tissue, adipokines, and inflammation. [J Allergy Clin Immunol. 2005]

Fantuzzi G

J Allergy Clin Immunol. 2005 May; 115(5):911-9; quiz 920.
Obesity-induced inflammatory changes in adipose tissue. [J Clin Invest. 2003]

Wellen KE, Hotamisligil GS

J Clin Invest. 2003 Dec; 112(12):1785-8.
Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. [Int J Obes (Lond). 2005]

Christiansen T, Richelsen B, Bruun JM

Int J Obes (Lond). 2005 Jan; 29(1):146-50.
Review Adipose tissue, inflammation, and cardiovascular disease. [Circ Res. 2005]

Berg AH, Scherer PE

Circ Res. 2005 May 13; 96(9):939-49.
Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. [J Biol Chem. 2002]

Ryden M, Dicker A, van Harmelen V, Hauner H, Brunnberg M, Perbeck L, Lonnqvist F, Arner P

J Biol Chem. 2002 Jan 11; 277(2):1085-91.
TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. [J Cell Biochem. 2003]

Souza SC, Palmer HJ, Kang YH, Yamamoto MT, Muliro KV, Paulson KE, Greenberg AS

J Cell Biochem. 2003 Aug 15; 89(6):1077-86.
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. [Science. 1993]

Hotamisligil GS, Shargill NS, Spiegelman BM

Science. 1993 Jan 1; 259(5091):87-91.
Tumor necrosis factor alpha inhibits signaling from the insulin receptor. [Proc Natl Acad Sci U S A. 1994]

Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM

Proc Natl Acad Sci U S A. 1994 May 24; 91(11):4854-8.
A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. [Arterioscler Thromb Vasc Biol. 2005]

Suganami T, Nishida J, Ogawa Y

Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2062-8.

Obesity-induced inflammatory changes in adipose tissue. [J Clin Invest. 2003]

Wellen KE, Hotamisligil GS

J Clin Invest. 2003 Dec; 112(12):1785-8.
Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. [Am J Physiol Endocrinol Metab. 2004]

Berg AH, Lin Y, Lisanti MP, Scherer PE

Am J Physiol Endocrinol Metab. 2004 Dec; 287(6):E1178-88.
In vivo imaging of NF-kappa B activity. [J Immunol. 2002]

Carlsen H, Moskaug JØ, Fromm SH, Blomhoff R

J Immunol. 2002 Feb 1; 168(3):1441-6.
Review NF-kappaB regulation in the immune system. [Nat Rev Immunol. 2002]

Li Q, Verma IM

Nat Rev Immunol. 2002 Oct; 2(10):725-34.

Review Inhibitors of NF-kappaB signaling: 785 and counting. [Oncogene. 2006]

Gilmore TD, Herscovitch M

Oncogene. 2006 Oct 30; 25(51):6887-99.
Review Biological effects of curcumin and its role in cancer chemoprevention and therapy. [Anticancer Agents Med Chem. 2006]

Singh S, Khar A

Anticancer Agents Med Chem. 2006 May; 6(3):259-70.
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. [Mol Pharmacol. 2006]

Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB

Mol Pharmacol. 2006 Jan; 69(1):195-206.
NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome. [Blood. 2006]

Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F, Kiladjian JJ, Ribrag V, Fenaux P, Kroemer G

Blood. 2006 Feb 1; 107(3):1156-65.
Review Targeting transcription factors for cancer therapy. [Curr Pharm Des. 2005]

Redell MS, Tweardy DJ

Curr Pharm Des. 2005; 11(22):2873-87.
Review Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). [J Altern Complement Med. 2003]

Chainani-Wu N

J Altern Complement Med. 2003 Feb; 9(1):161-8.
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. [Anticancer Res. 2001]

Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY

Anticancer Res. 2001 Jul-Aug; 21(4B):2895-900.
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. [J Med Chem. 2006]

Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM, Orlando RA, Deck LM, Jagt DL

J Med Chem. 2006 Nov 30; 49(24):7182-9.
Review Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. [Mutat Res. 2004]

Kundu JK, Surh YJ

Mutat Res. 2004 Nov 2; 555(1-2):65-80.
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. [Carcinogenesis. 2006]

Kundu JK, Shin YK, Kim SH, Surh YJ

Carcinogenesis. 2006 Jul; 27(7):1465-74.
High absorption but very low bioavailability of oral resveratrol in humans. [Drug Metab Dispos. 2004]

Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK

Drug Metab Dispos. 2004 Dec; 32(12):1377-82.
Human, rat, and mouse metabolism of resveratrol. [Pharm Res. 2002]

Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB

Pharm Res. 2002 Dec; 19(12):1907-14.
Review Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. [Anticancer Res. 2004]

Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y

Anticancer Res. 2004 Sep-Oct; 24(5A):2783-840.

Review Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. [Cell Mol Immunol. 2007]

Carmody RJ, Chen YH

Cell Mol Immunol. 2007 Feb; 4(1):31-41.
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. [Endocrinology. 2004]

Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW

Endocrinology. 2004 May; 145(5):2273-82.

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. [Endocrinology. 2007]

Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF

Endocrinology. 2007 Jan; 148(1):241-51.
Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. [Diabetologia. 2006]

Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulangé A, Capeau J, Caron M

Diabetologia. 2006 Sep; 49(9):2162-73.

Review Clinical studies with curcumin. [Adv Exp Med Biol. 2007]

Hsu CH, Cheng AL

Adv Exp Med Biol. 2007; 595():471-80.
Review Pharmacokinetics and pharmacodynamics of curcumin. [Adv Exp Med Biol. 2007]

Sharma RA, Steward WP, Gescher AJ

Adv Exp Med Biol. 2007; 595():453-70.
Review Therapeutic potential of resveratrol: the in vivo evidence. [Nat Rev Drug Discov. 2006]

Baur JA, Sinclair DA

Nat Rev Drug Discov. 2006 Jun; 5(6):493-506.

Activation of NFkappaB is inhibited by curcumin and related enones. [Bioorg Med Chem. 2006]

Weber WM, Hunsaker LA, Roybal CN, Bobrovnikova-Marjon EV, Abcouwer SF, Royer RE, Deck LM, Vander Jagt DL

Bioorg Med Chem. 2006 Apr 1; 14(7):2450-61.
Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB. [J Med Chem. 2006]

Heynekamp JJ, Weber WM, Hunsaker LA, Gonzales AM, Orlando RA, Deck LM, Jagt DL

J Med Chem. 2006 Nov 30; 49(24):7182-9.

You are here: NCBI > Literature > PubMed Central (PMC)

Write to the Help Desk

PMC

Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes

Abstract

Background

Methods

Results

Conclusion

Articles from Nutrition & Metabolism are provided here courtesy of BioMed Central

Formats:

Related citations in PubMed

Cited by other articles in PMC

Links

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information